Fostamatinib Inhibits the Proliferation of Ovarian Cancer Cells Through Apoptosis Induction

Fostamatinib, by inhibiting cell proliferation and inducing apoptosis, shows promise as a repurposed therapeutic agent for ovarian cancer, potentially offering a new approach to improve patient outcomes.